SCFAs enhance metabolic functions of T2DM through FFAR3 (or GPR41) and FFAR2/GPR43 (e.g., controlling the blood glucose level, as well as IR and GLP-1 secretion) (Puddu et al., 2014). This evidence concerns the gene FFAR3 and type 2 diabetes mellitus.